214 related articles for article (PubMed ID: 23547895)
1. Presence of alternative lengthening of telomeres associated circular extrachromosome telomere repeats in primary leukemia cells of chronic myeloid leukemia.
Samassekou O; Malina A; Hébert J; Yan J
J Hematol Oncol; 2013 Apr; 6():26. PubMed ID: 23547895
[TBL] [Abstract][Full Text] [Related]
2. Alternative Lengthening of Telomeres (ALT) in Tumors and Pluripotent Stem Cells.
Zhao S; Wang F; Liu L
Genes (Basel); 2019 Dec; 10(12):. PubMed ID: 31835618
[TBL] [Abstract][Full Text] [Related]
3. Telomeres reforged with non-telomeric sequences in mouse embryonic stem cells.
Kim C; Sung S; Kim JS; Lee H; Jung Y; Shin S; Kim E; Seo JJ; Kim J; Kim D; Niida H; Kim VN; Park D; Lee J
Nat Commun; 2021 Feb; 12(1):1097. PubMed ID: 33597549
[TBL] [Abstract][Full Text] [Related]
4. Functional Loss of
Graham MK; Kim J; Da J; Brosnan-Cashman JA; Rizzo A; Baena Del Valle JA; Chia L; Rubenstein M; Davis C; Zheng Q; Cope L; Considine M; Haffner MC; De Marzo AM; Meeker AK; Heaphy CM
Mol Cancer Res; 2019 Dec; 17(12):2480-2491. PubMed ID: 31611308
[TBL] [Abstract][Full Text] [Related]
5. Effects of reconstitution of telomerase activity on telomere maintenance by the alternative lengthening of telomeres (ALT) pathway.
Grobelny JV; Kulp-McEliece M; Broccoli D
Hum Mol Genet; 2001 Sep; 10(18):1953-61. PubMed ID: 11555632
[TBL] [Abstract][Full Text] [Related]
6. Variant repeats are interspersed throughout the telomeres and recruit nuclear receptors in ALT cells.
Conomos D; Stutz MD; Hills M; Neumann AA; Bryan TM; Reddel RR; Pickett HA
J Cell Biol; 2012 Dec; 199(6):893-906. PubMed ID: 23229897
[TBL] [Abstract][Full Text] [Related]
7. Alternative lengthening of telomeres in cancer stem cells in vivo.
Bojovic B; Booth RE; Jin Y; Zhou X; Crowe DL
Oncogene; 2015 Jan; 34(5):611-20. PubMed ID: 24531712
[TBL] [Abstract][Full Text] [Related]
8. Alternative Lengthening of Telomeres in the Budding Yeast
Cohn M; Andersson AK; Mateo RQ; Möller MC
G3 (Bethesda); 2019 Oct; 9(10):3345-3358. PubMed ID: 31427453
[TBL] [Abstract][Full Text] [Related]
9. Differential Regulation of Telomeric Complex by
Deregowska A; Pepek M; Pruszczyk K; Machnicki MM; Wnuk M; Stoklosa T
Genes (Basel); 2020 Sep; 11(10):. PubMed ID: 33003326
[TBL] [Abstract][Full Text] [Related]
10. Telomere-maintenance mechanisms in soft-tissue malignant fibrous histiocytomas.
Matsuo T; Shay JW; Wright WE; Hiyama E; Shimose S; Kubo T; Sugita T; Yasunaga Y; Ochi M
J Bone Joint Surg Am; 2009 Apr; 91(4):928-37. PubMed ID: 19339578
[TBL] [Abstract][Full Text] [Related]
11. Telomere elongation via alternative lengthening of telomeres (ALT) and telomerase activation in primary metastatic medulloblastoma of childhood.
Minasi S; Baldi C; Pietsch T; Donofrio V; Pollo B; Antonelli M; Massimino M; Giangaspero F; Buttarelli FR
J Neurooncol; 2019 May; 142(3):435-444. PubMed ID: 30830680
[TBL] [Abstract][Full Text] [Related]
12. Single-molecule analysis of subtelomeres and telomeres in Alternative Lengthening of Telomeres (ALT) cells.
Abid HZ; McCaffrey J; Raseley K; Young E; Lassahn K; Varapula D; Riethman H; Xiao M
BMC Genomics; 2020 Jul; 21(1):485. PubMed ID: 32669102
[TBL] [Abstract][Full Text] [Related]
13. Mutant telomeric repeats in yeast can disrupt the negative regulation of recombination-mediated telomere maintenance and create an alternative lengthening of telomeres-like phenotype.
Bechard LH; Butuner BD; Peterson GJ; McRae W; Topcu Z; McEachern MJ
Mol Cell Biol; 2009 Feb; 29(3):626-39. PubMed ID: 19029249
[TBL] [Abstract][Full Text] [Related]
14. Alternative Lengthening of Telomeres (ALT) and Telomerase Reverse Transcriptase Promoter Methylation in Recurrent Adult and Primary Pediatric Pituitary Neuroendocrine Tumors.
Alzoubi H; Minasi S; Gianno F; Antonelli M; Belardinilli F; Giangaspero F; Jaffrain-Rea ML; Buttarelli FR
Endocr Pathol; 2022 Dec; 33(4):494-505. PubMed ID: 34993885
[TBL] [Abstract][Full Text] [Related]
15. DNA methylation mediated up-regulation of TERRA non-coding RNA is coincident with elongated telomeres in the human placenta.
Novakovic B; Napier CE; Vryer R; Dimitriadis E; Manuelpillai U; Sharkey A; Craig JM; Reddel RR; Saffery R
Mol Hum Reprod; 2016 Nov; 22(11):791-799. PubMed ID: 27604461
[TBL] [Abstract][Full Text] [Related]
16. The relationship between telomere length and therapy-associated cytogenetic responses in patients with chronic myeloid leukemia.
Iwama H; Ohyashiki K; Ohyashiki JH; Hayashi S; Kawakubo K; Shay JW; Toyama K
Cancer; 1997 Apr; 79(8):1552-60. PubMed ID: 9118038
[TBL] [Abstract][Full Text] [Related]
17. Divergent patterns of telomere maintenance mechanisms among human sarcomas: sharply contrasting prevalence of the alternative lengthening of telomeres mechanism in Ewing's sarcomas and osteosarcomas.
Ulaner GA; Hoffman AR; Otero J; Huang HY; Zhao Z; Mazumdar M; Gorlick R; Meyers P; Healey JH; Ladanyi M
Genes Chromosomes Cancer; 2004 Oct; 41(2):155-62. PubMed ID: 15287028
[TBL] [Abstract][Full Text] [Related]
18. Telomere dynamics and cytogenetic changes in human hematologic neoplasias: a working hypothesis.
Ohyashiki K; Ohyashiki JH
Cancer Genet Cytogenet; 1997 Mar; 94(1):67-72. PubMed ID: 9078293
[TBL] [Abstract][Full Text] [Related]
19. ALT: A Multi-Faceted Phenomenon.
Sommer A; Royle NJ
Genes (Basel); 2020 Jan; 11(2):. PubMed ID: 32012790
[TBL] [Abstract][Full Text] [Related]
20. Telomere maintenance in Wilms tumors: first evidence for the presence of alternative lengthening of telomeres mechanism.
Venturini L; Daidone MG; Motta R; Collini P; Spreafico F; Terenziani M; Piva L; Radice P; Perotti D; Zaffaroni N
Genes Chromosomes Cancer; 2011 Oct; 50(10):823-9. PubMed ID: 21769957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
